ROTH Financials 07/16/2014 13:17:04
PharmaRoth Labs, Inc.
Period Ending Jun 30, 2013 Jun 30, 2012
Total Revenue 154 605
Cost of Revenue 120 462
Gross Profit 34 143
Operating Expenses
Research and Development - -
Sales, General and Admin. 461 312
Non-Recurring Items - -
Other - -
Operating Income (427) (169)
Income From Continuing Operations
Add'l Income/Expense Items - 8
Earnings Before Interest and Tax (427) (161)
Interest Expense - -
Earnings Before Tax (427) (161)
Income Tax - -
Minority Interest (2) (1)
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (425) (160)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (425) (160)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (425) (160)